Post Show Report · pharmaceutical exhibition with hundreds of conferences and activities held onsite, shows the latest development trends and advanced technologies in global pharmaceutical
Post on 25-Apr-2020
1 Views
Preview:
Transcript
www.cphi.com/china www.cphi.com/p-mec-china
Post Show Report
Asia's leading trade & networking platform covering the entire pharma industry chain
Concurrently held with:
June 20-22, 2018 Shanghai New Int'l Expo Centre (SNIEC)
2019
1
3
6
9
10
15
16
Contents
Show Profiles
2nd China Pharma Week
Visitors: 2018 Facts & Figures
Exhibitors: 2018 Facts & Figures
2018 Onsite Conferences & Activities
From Online to Offline
Photo Gallery & 2019 Outlook
Organised by UBM EMEA in collaboration with China Chamber of Commerce for Impor t & Expor t of Medicines & Health Products and co-organised by Shanghai UBM Sinoexpo International Exhibition Co, CPhI and its co-located events – ICSE, NEX, BioPh China, P-MEC, InnoPack and LABWorld China – concluded successfully at Shanghai New International Expo Centre on June 22.
Advancing continuously over the past 18 years, CPhI & P-MEC China has not only set up a giant international platform for China's pharmaceutical industry, but also witnessed the country's huge development in the 40 years of pharmaceutical reform from meeting the drug
Getting Access to the Entire Pharma Supply Chain Under One Roof
Building a Global Leading Pharmaceutical Industry Platform
demands in China to opening overseas mainstream markets. Hitting new records again in 2018, the show scale of CPhI & P-MEC China reached 180,000m2, while the exhibitor number reached 3,022 and the total number of visits 60,744, growing by 10% since 2017. The number of international visitors has increased massively reaching 15,329 – over 50% more visits from abroad than in 2017.
CPhI & P-MEC China, the leading pharmaceutical trade show in China and wider Asian - Pacific region, will make a big comeback on June 18-20, 2019 at SNIEC to offer again an international-level and high-quality pharmaceutical trade fair.
Record-Breaking Numbers in All Areas
3,022Total Exhibitors
15,329Overseas Number of Visits
60,744Total Visits
180,000 Exhibition Area (Square Meter)
APIsFine Chemicals &
Intermediates
Excipients & Formulation
AnimalHealth
CMO & CRO
Natural Extracts
Biopharmaceuticals
Packaging Materials
PharmaLogistics
Environmental Protection & Clean
Technology
Laboratory Equipment
Pharmaceutical Machinery
FDF
2 3
Name List ofOpening Ceremony
Mr. Zhou Hui, President of China Chamber of Commerce for Import & Export of Medicines & Health Products
Mr. Jime Essink, CEO of UBM Asia
Mr. Zhang Wei,Secretary General of Chinese Pharmacopoeia Commission
Mr. John van der Valk,Managing Director of UBM EMEA
Mr. Xu Xingfeng, Deputy Special Commissioner of Shanghai Special Commissioner's Office of Ministry of Commerce of China
Mr. Jerome Lepeintre,Minister Counsellor for Health and Consumers, Delegation of the European Commission in Beijing
Mr. Wang Qiang, Chairman of the board of Donghao Lansheng (Group) Co. Ltd.
Mr. Alexey Alekhin,Head of Department of pharmaceutical and medical industry development,Ministry of Industry and Trade of the Russian Federation
Mr. Gao Zhiqiang, Director of China International Import Expo Bureau
Mr. Mazin M. AL Ismaiel,Executive Director of Public Relations,Saudi Food Drug Authority
Mrs. Caroline Larsen Le Tarnec,Head of Public Relations & Documentation Division,European Directorate for the Quality of Medicines & HealthCare (EDQM, Council of Europe)
Mr. Hideo Tsunoda, Chairman of Japan Pharmaceutical Traders' Association
Mr. Oh Jang Suk, Chairman of Korea Pharmaceutical Traders Association
Mrs. Kang Wei, Managing Director of China Association of Enterpr i ses wi th Fore ign Investment , R&D -based Pharmaceutical Association Committee
Mrs. Zhu lihong, Senior Vice President and Managing Director, DIA Greater China
Gathering Industry Leaders, Establishinga New Chapter of the Pharmaceutical Industry
Themed by how to guarantee the balance and stability of
API supply chain, the summit invited leaders of representative
enterprises in the industry to a round table discussion. They
shared successful experiences and advice to address the above
challenges, providing insight into how to resolve the current
development predicament that enterprises are facing.
CPhI Networking DinnerThe networking dinner took place on the evening of June 20th
at the Bund. 200 government officials, Chinese and overseas
VIP buyers and pharmaceutical company executives shared
insights with industry peers from all over the world. They
broadened the high-end connections in the industry while
enjoying the night view of Huangpu River and tasting the
dinner delicacies.
The 9th China-World CEO Summit
2nd “China Pharma Week” inherits its high quality
The 5-day China Pharma Week was launched in Shanghai and surrounding areas in 2018 with 20 extended events to cover the Leadership, Business, Networking, Recognition, Knowledge, and Innovation of the pharmaceutical industry.
The conferences cover a wide range of topics, including analysis of Chinese and international pharmaceutical laws, regulations and new policies, interpretation of latest patents and intellectual property, green process transformation, etc., and the events were diversified, from the heavyweight industry awards, women in leadership forum to factory visit, and C-level networking dinner etc., to build an annual high-end pharmaceutical industry event that integrates trade, socializing, and knowledge sharing.
4 5
CPhI Women in Leadership Forum
The 2018 Award for Top 100 Internationalized Companies
The forum was successfully held at Le Sun Chine one night
before the show, to unveil the China Pharma Week. Themed by
"new era, new women, new health", the forum gathered over
60 women leaders of the pharma industry to share life insights
and talk about experience in the workplace.
Excellent Suppliers and Partners in International Market (Top
60), Leading Formulation Suppliers (Top 20), and Promising
Enterprises (Top 20) were selected on the basis of product export,
international registration, overseas M&A, and international
cooperation, etc. The lists were released before the show, and
published to all exhibitors and visitors on-site.
CPhI China International Business Programme
Plant Visit
Featuring two tracks, the International Business Programme
was developed with both domestic and international visitors
in mind. The sessions addressed the key trends, topics and
developments for international partners looking to expand to
or within the Chinese market and domestic partners looking
to grow operations outside of China or draw learnings from
international partners.
The Plant Visit continued the splendidness of the show after
closing on June 22nd. The organiser orchestrated 3 routes:
Cutting-edge System & Engineering, Scientific & Innovative
Instruments, and Amino Acid Manufacturing, leading nearly
40 professional visitors to the plant, which facilitated potential
partners to get in touch with the culture and technology of
suppliers closely, and feel the strength of 'Made in China'.
Exhibitor Testimonials
CPhI Shanghai is a must to attend if you have anything to do with China related pharma
business. It is not only for the raw materials but also provides great candidates for sales
operations and other areas like packages, CMO and machinery. Highly recommended!
Petri Karvinen, Orion Pharma, Head of China Operations................................................................................................................CPhI is an awesome event where people working in the pharmaceutical industry can learn
more.
Gonzalo Macoco Tabarez, Gonzalo, R&D Manager................................................................................................................China is practically the pharmacy of the world, you will get the best prices and just a huge
number of products from China and from India. We are really meeting very good products
and very good companies.
Ameeta Michelle Panemanglor, Business Development Manager, S.M.H.P Marketing & Consultancy............................................................................................It's a great opportunity for me to meet all people coming to CPhI China, from
all over South East Asia, that's a great opportunity.
Philippe Maigrot, Global Pharma Channel Strategy Director, Dow Consumer Solutions
Visitor Testimonials
Here it's a good opportunity to find new collaboration, new suppliers, new partners, you can find everybody in this show.
Norberto Prestes, Director, Brazilian API Industry Association
It's very important to be here, to understand that the very quick development of this market, to understand also the culture of this market.
Tommaso Broia, Export Area Manager APAC, Bormioli PharmaIndustry Association
CPhI China is a great platform that connects with international and domestic market and broadens the industry chain. Our company finds more international partnerships and promotes our international brand awareness here.
Tan Jahong, Deputy GM, Huzhou Zhanwang Pharmaceutical Co., Ltd
6 7
2015-2018 Overseas Visits
Visitors: 2018 Facts & Figures
Top 15 Overseas Visiting Countries
Visitor Continent Breakdown
Canada
U.S.A.
Spain
Switzerland Italy
Iran
India
Australia
Philippines
Japan
South Korea
Bangladesh
Germany
Russia
Pakistan
Increase
Increase
Increase
Visitor Job Title & Purchasing Power Analysis
(The above data is based on the onsite and post show survey.)
Visitor Company Business Breakdown (Top 8) Visitor Interest Area (Top 8)
Nearly 50% of the visitors are decision
makers, gathering high-end pharmaceutical
business ecosystem.
Pharmaceutical Company
Pharmaceutical Marketing Company
New Drug R&D
Fine Chemical Manufacturing
Contract Manufacturing & Outsourcing
Environmental Protection & Clean Engineering
Food & Beverage, Health Food Company
Biotech Company
25.7%Purchasing Department
1.4%Other
21.0%Sales / Marketing Department
16.6%R&D Department
7.6%Foreign Trade
Department
6.4%QC/QA Department
6.2%Safety and
Environmental Protection
5.3%Production Department
4.3%Engineering Management
3.2%Administrative Management
1.8%Logistics Department 30.0%
Manager / Project Manager /Department Head
19.6%
President / Chairman /CEO / General Manager
18.7%
10.0%
9.5%
8.1%
7.7 %
7.1%
7.0%
6.6%
IngredientsCPhI
Finished Dosage Formulation
FDF
Excipients & Formulation
PackagingInnoPack
Natural ExtractNEX
BiopharmaceuticalsBioPh
Machinery, Equipment, Technology
P-MEC
Laboratory EquipmentLABWorld
66%
29%
27%
25%
24%
22%
20%
20%
8 9
Domestic Visitors by China Provinces
Well-Received by Visitors, Record-Breaking Satisfaction Rates
Visitors were highly satisfied with CPhI & P-MEC China 2018.
Henan HubeiGuangdong Shandong JiangsuAnhui
Hebei Beijing Zhejiang Shanghai
Visitors will continue to attend CPhI & P-MEC China.
Visitors would recommend CPhI & P-MEC China to co-workers and industry partners.
(Top 10 Provinces)
Exhibitors Highly-Satisfied with Onsite Visitor Numbers
of exhibitors will return to CPhI & P-MEC China in 2019
of exhibitors were satisfied with the 2018 event
of exhibitors will recommend it to co-workers and industry partners
Exhibitors: 2018 Facts & Figures
10 11
CPhI and P-MEC China, as a leading international
pharmaceutical exhibition with hundreds of conferences
and activities held onsite, shows the latest development
t r e n d s a n d a d v a n c e d t e c h n o l o g i e s i n g l o b a l
pharmaceutical industry. This year, it involved more than
200 industry experts and attracted over 4,000 attendees to
participate actively.
Various themed conferences and activities were designed
to fit into the relevant industry chain of the show, which
attracts more and more professionals from pharmaceutical
engineering, QC/QA, certification, R&D and supply chain
department etc. as well as officials from supervision
Various Extended Onsite Conferences & Activities
department and experts from research institutes and
colleges and promotes multi-faced exchange and
integration.
The onsite conferences cover a wide range of topics,
including analys i s of Chinese and internat ional
pharmaceutical laws, market analysis of key export
countries and experience sharing of overseas market
development etc. and the events were diversified, from the
heavyweight industry awards, C-level networking dinner
to plant visit and innovation tour. Various conferences and
activities well extended the exhibition, which facilitate
business negotiation and social networking for all pharma
professionals.
2018 Onsite Conferences
China-World Innovation and Development Forum
The speeches of the forum were focused on the policy and market which covered the pharmaceutical
industry development situation and policy trends, CFDA's latest reforms and influences thereof, analysis of
the import & export and internationalisation situation of Chinese pharmaceutical products, pharmaceutical
product patent protection, and market access and regulation, etc., to provide a high-level exchange
platform for Chinese and overseas pharmaceutical entrepreneurs, industry experts, and relevant
government departments, and offer keen insights and thorough analysis of the new environments and new
situations of development of the Chinese and overseas pharmaceutical industries from the perspective of
globalisation strategy.
- June 20-21, 2018-
CPhI International Agencies Updates and Q&A: Japan & China Session
Experts from China National Drug Administration, Chinese Pharmacopoeia Commission,
Center for Food and Drug Inspection of CFDA, Shanghai Municipal Food and Drug
Administration, Delegation of the European Union to China, World Health Organization,
U.S. Food and Drug Administration, European Directorate for the Quality of Medicines
& HealthCare, United States Pharmacopeia Convention, British Standards Institute and
Saudi Food and Drug Authority, etc. together with over 200 representatives from nearly
100 enterprises were present at the conference. The conference has been held for
consecutive years, inviting Chinese and overseas pharmacopoeia and drug regulation
agencies to share the recent dynamics of drug regulatory policies, laws and regulations
and help enterprises improve levels in product registration application and quality system
construction, which is not only a high-end, open, and sharing platform for Chinese
and overseas pharmaceutical industries to exchange on drug regulatory laws and
regulations, but also an important window for Chinese pharmaceutical industry to be
synonymous with international standards.
- June 20, 2018-
The 1st CHP-JP Joint Forum
was succes s f u l l y he ld
in Shanghai on June
2 1 b y C h i n e s e
P h a r m a c o p o e i a
C o m m i s s i o n a n d
Society of Japanese
P h a r m a c o p o e i a ,
w i t h o v e r 2 0 0
representatives from
the China National Drug
Administration, Ministry of
Health, Labour and Welfare
of Japan, Pharmaceuticals
and Medical Devices Agency
of Japan, Chinese Pharmacopoeia
Commission, National Institutes for Food
and Drug Control of China, and Chinese and Japanese institutions for
pharmaceutical product research, production, and control present.
- June 21, 2018-
CPhI International Agencies Updates and Q&A
China and India, the two major
countries developing rapidly in the
pharma industry, have attracted
w o r l d w i d e a t t e n t i o n . I n d i a i s
the world's largest producer of
generic drugs, known as the "world
pharmacy" while China possesses
the most complete supply system of
pharma industry chain. The organizer
invited industry leaders from the two
countries to discuss the cooperation
and competit ion of China-India
pharma industry from various aspects
and angles, introduce the overall
situation of China-India pharma
market, analyse the advantages of
China-India pharma industry and
the investment guidance of Indian
pharma industry.
P-MEC China Summit 2018
The P-MEC China Summit 2018 lasted
for three days (June 20-22) and
came to a successful conclusion,
where lively and detailed speeches
were given mainly focusing on
topics like “Rationality of Deviation
I n v e s t i g a t i o n a n d E f f e c t i v e
Management of CAPA”, “Technology
Transfer Requirements in MAH”,
and “ Lean Manufactu r ing o f
Pharmaceuticals: How to create
rea l compet i t i venes s t h rough
effective integration with QA/QC”,
with an audience of nearly 200
people and fantastic interactions
during the discussion to let wisdom
sparkle in the clash of ideas; i t
provided insiders with an excellent
platform for analysing policies and
regulations, discussing quality culture
development, qualif ication and
validation, and data integrity, and
showcasing the latest technologies.
- June 20-22, 2018-
- June 21, 2018-
The Cooperation-Competitionof China-India Pharma Industry
12 13
2018 Onsite Conferences
The International Summit for Pharmaceutical Packaging & Drug Delivery System
Drug Safety and Quality Management Forum 2018
As the competition in global pharmaceutical market grows, how to enhance drug efficacy faster
and more accurate and how to improve the patients' experience of taking medicines by improving
the way of drug delivery has become one of the focuses for pharmaceutical enterprises. The
summit kept fingers firmly on hot topics of overseas and
domestic pharmaceutical packaging industry and
discussed the policy trends and the new design and
technology of drug delivery of solid, oral and injection
preparations, which provides a great platform for more
than 200 delegations to communicate with international
pharmaceutical packaging experts.
Kicked off on June 21, the 5th China BioPh Outlook Summit, an important
conference of the biopharmaceutical industry, invited over 20 Chinese and
oversea senior pharmaceutical experts to form a luxury speaker lineup, from
well-known pharmaceutical enterprises like Amgen, Bayer, Roche, Henlius, WuXi
AppTec, and Simcere, and professional agencies like Shanghai Biopharmaceutics
Industry Association, Shanghai Drug Evaluation and Inspection Center, SAPA, and
RDPAC, to focus on analysis of Chinese and overseas biological drug markets and
policies, explore the R&D trends of innovative biological drugs, discuss the new
R&D trends of anti-cancer drugs, and share about the new developments of tumor
immunotherapy and other hot topics. Over 300 industry elites were present on site,
to "feel the pulse" for the future of China's biopharmaceuticals.
- June 20-22, 2018-
- June 21, 2018-
On June 20, experts from the government, drug regulators, Chinese and
overseas enterprises, and research institutes conducted heated discussions
and exchanges by following China's quality management system under the
new situation, tracking of the latest regulatory policies for pharmaceutical
product safety, exploration of drug safety detection and risk control, and
application of new biological technologies, etc. This forum enabled attendees
to see the development trends and bright prospects of China's bio-medicine
industry, and that the drug R&D will raise higher requirements for China's
laboratory instrument industry.
- June 20, 2018-
5th China BioPh Outlook Summit
The forum gathered an advisory group in the environmental policy field of China and an expert panel on
environmental equipment and technology, to discuss the application of the environmental protection
technology in the pharmaceutical industry under the New Normal, and bring interpretations of the
latest pharmaceutical environmental protection policies and green and environmental protection
application solutions.Furthermore, to respond to China’s call for green manufacturing, promote energy
conservation and emission reduction and clean production, resist violations of environmental laws
and regulations, and drive green transformation and upgrading and sustainable development of the
pharmaceutical industry, the “Pharmaceutical Industry Green Development Initiative” initiated by All-
China Environmental Federation, CCCMHPIE, and UBM Sinoexpo, and actively responded by North China
Pharmaceutical Group Corporation, Hangzhou Lanran Environmental Technology Co., Ltd., Asymchem
Laboratories (Tianjin) Co., Ltd., Yangtze River Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical
Co., Ltd., DSM Sinochem Pharmaceuticals Limited, Zhejiang Liuhe Engineering Technology Co., Ltd., Zhejiang
Guobang Pharmaceutical Co., Ltd., and Beijing Key Laboratory of Resource-Oriented Treatment of Industrial
Pollutants of University of Science and Technology Beijing was released to the whole industry, to call for performing
environmental responsibilities and keeping the commitment for green development.
- June 20, 2018-
China Pharma Environmental Forum
2018 Onsite Activities
NEX High Quality Suppliers Gallery
In recent years, the plant extracts industry has maintained rapid growth. How to stand out in many plant extracts enterprises has
not only become an urgent demand for them, but also the focus of the buyers. The organizer specifically set up a display area of
quality suppliers of natural extracts at Hall E4 No. A02 booth. It was to display quality suppliers of plant extracts and their products
which have been initiated by CCCMHPIE together with NSF, USP, SGS, and Intertek, offering the NEX visitors a well-prepared mini-
show.
2018 InnoLAB Salon brought together
cutting-edge information and popular
products in the pharmaceutical laboratory
field and focused on two characteristic
topics: Innovation of Chromatographic
Technology and Construction of Intelligent
Laboratory. The Salon also gathered many
of the world's leading laboratory solution
providers, which provides a
platform of deep knowledge-
s h a r i n g a n d a c c u r a t e
networking for R&D, testing
and QA/QC professionals,
helps the construction of
pharmaceutical laboratory
and advances the R&D of
instruments.
此次沙龙汇集了制药实验室领域前沿资讯及热点产品,聚焦两大特
色主题,包括“色谱技术创新”和“智能实验室建设”,并汇聚了
众多全球知名实验室解决方案提供商,为药厂研发、检 /QA/QC 人
员提供了一个深层次的知识共享与精准人脉构建平台,助力医药实
验室建设,推进仪器研发大步向前。
2018 Innolab Salon
14 15
2018 Onsite Activities
P-MEC Overseas Buyer Group
In order to help Chinese pharmaceutical machinery and
equipment to go aboard, the organiser specially invited
nearly 50 overseas pharmaceutical machinery buyers from
Russia, Ukraine, Netherlands, France, Pakistan and Nepal
etc. to the event together with several partners. Among
these buyers, 18 of them had one-on-one conversations
with Chinese pharmaceutical machinery suppliers. A
number of overseas buyers not only expressed the strong
interest of suppliers' products onsite, but also extended
further contact with the supplier after the exhibition.
Pharmaceutical Packaging & Drug Delivery System Innovation Gallery & Tour
Taking "Innovative Drug Delivery Solutions" and "Solid
Preparation Packaging Solutions" as the subjects, this year's
activity brought visitors quality products excelling at patient
compliance, durability and automation. The high quality of the
products and enthusiastic response from visitors once again
proved that innovation and humanized design are not only the
market positioning of InnoPack China, but also at the core of
drug packaging development.
Pharma Clean Technology Innovation Tour
The tour was led by Mr. Wang Hongzhou from Suzhou Mei Mate Information
Consulting Co., Ltd. Over 10 professional visitors from engineering
department, equipment technology department and purchasing
department of pharma companies were guided to the specific booth of
pharma clean solutions including automation equipment from Longxin
and purification equipment from Rongdaxing. They also visited Honghai,
a company with 2500 ton automatic extrusion production line, Yeshine, a
leading high-tech joint venture, DST, Swedish desiccant equipment Supplier,
and Foster Wheeler AG, an engineering contracting company. Visitors
exchanged deep views with experts in pharma clean solutions and gained
the latest pharma clean solution products and market development trends.
One-stop Purchasing Platform from Online to OfflineCPhI.CN Evokes the Digital Pharma Trend
Meet Industry Big Shots
“CPhIdea Hub” Live Broadcast
Over 30 industry experts interacted with onsite visitors in relation to the
pharmaceutical industry market development, technology trends, new
product advantages, and policy changes, etc. in the interview room
and they aired respective views.
China Pharma Connect
New Matchmaking Tool Facilitates Onsite
Meetings
A new pre-show matchmaking platform - China
Pharma Connect was tailor made for exhibitors and
visitors this year to help each other find potential
partners and arrange onsite meetings before the
show, which successfully facilitated over 8,043
meetings across 3 days.
Taking Advantage of Mobile Internet
“Pharmaceutical Online Marketing Seminar”
The Pharmaceutical Online Marketing Seminar was fully attended, where CPhI.
CN analysed how to accomplish online marketing from the shallower to the
deeper and layer by layer together with Toutiao, adSage, a leading digital
marketing service provider, and Weimob, a mobile socialising expert.
In addition, the 360°panoramic VR experience show gave a real
reproduction of brand images, products and services, etc. of the exhibitors,
to enable visitors to experience the brand’s services on-site without the
need to make arduous journeys. The “Brain Quest” provided over 5,000
pharmaceutical associated questions, which made visitors eager for trying
and linger on.
International Business Opportunities Near at Hand
8th CPhI Buyers Sourcing Event Successfully Held
The 8th CPhI Buyers Sourcing Service invited international buyers to
achieve zero-distance negotiations: 150 buyers participated, and 551
cooperation negotiations took place in 2 days, realising a super high
sourcing efficiency. Through one-to-one and face-to-face way of talk,
the service team helped China's suppliers build business relationship
with international buyers.
16 17
Onsite Photo GalleryCPhI & P-MEC China 2019 will be held at Shanghai New International Expo Centre on June 18-20. The show will cover all halls of Shanghai New International Expo Centre for the first time, and is expected to reach 200,000m2 and attract over 3,200 Chinese and overseas exhibitors and more than 70,000 visits by professional visitors from
over 120 countries and regions, to create the strongest lineup in its history, which is not to be missed!Delivering a high quality event which reflects perfectly the potential of the market has always been the aspiration of the organizers. The 2019 event layout will propose reshaped zones as a result of the industry trends and market
demand.
BioPh China will be upgraded to bioLIVE China and move to Hall W4. It will focus on life sciences, biotechnology and innovative drugs and build Asia's premier partnering platform covering the whole pharmaceutical industry chain from small to large molecule together with CPhI China.LABWorld China will be extended to Hall W5.NEX China will move to Hall E4 and Hall E5.PharmaExcipients China will move to Hall E3.Animal Health & Feed Zone will move to Hall E7.
Remaining true to the original aspiration and forging ahead over the 18 years, the organiser will adhere to the spirit of "be the best", live up to the trust, advance together with insiders and industry enterprises, and help with the construction of the new structure of pharmaceutical industry.
CPhI & P-MEC China 2019 Outlook: New Layout, New Start
2019 Event Overview
SNIEC
P-MEC
& LA
BWo
rldIne
rnatio
nal A
rea
Animal Health
North
South
East
花木路
bioLIVE
2019
CPhI & P-MEC China 2019June 18-20, 2019
See You in SNIEC, Shanghai, Pudong
www.cphi.com/chinawww.cphi.com/p-mec-china
UBM EMEAUBM EMEA | International Exhibitions | de Entree 73 Alpha Tower | 1100BH Amsterdam | The NetherlandsTel: +31 20 708 1605Fax: +31 20 36 32 616Contact: Dina Strelkovadina.strelkova@ubm.com
CCCMHPIE12F,3# Bldg., Beijing INN, No 6Nanzhugan Hutong, Dongcheng Dist. Beijing100010, China,Tel: +86-10-5803 6296Fax: +86-10-5803 6319Contact: Ms. Wuwuyushuang@cccmhpie.org.cn
UBM Sinoexpo7-8/F., 355 Hong Qiao Rd.Shanghai 200030, ChinaTel: +86-21-3339 2250 / 2255Fax: +86-21-33250710Contact: Ms. Mao/Ms. Fengchris.mao@ubmsinoexpo.comiris.feng@ubmsinoexpo.com
top related